Consorzio Interuniversitario Nazionale per la Bio-Oncologia www.cinbo.org
DIRECTOR Clara Natoli SCIENTIFIC SECRETARIAT
Consiglia Carella Michele De Tursi Antonino Grassadonia
Nicola Tinari
SCIENTIFIC ADVISORY BOARD Vincenzo Adamo
Barbara Barboni Roberto Bianco Giovanni Brandi Marco Carini Leonardo Della Salda
Corrado Ficorella Francesco Grignani
Lorenzo Lo Muzio Patrizia Querzoli
Antonio Russo Marina Scarpelli
Silverio Tomao Giuseppe Tonini ORGANIZING SECRETARIAT
Giovanna Di Credico OFFICES
Consorzio Interuniversitario Nazionale per la Bio-Oncologia (CINBO) c/o Sezione di Oncologia Medica Università G. D’Annunzio - Via dei Vestini, 31
66100 Chieti - Italy Phone: +39 0871 3556732
Fax +39 0871 3556707 [email protected] PROVIDER ECM ID. 50
Strategie S.r.L. - Via Piave 110/7 - Pescara Phone: 085 74143 - Fax: 085 378220
[email protected] www.strategieonweb.it
Consorzio Interuniversitario Nazionale per la Bio-Oncologia
presents
BREAST CANCER
from bench to bedside
June 15, 2017
Sala Convegni
Centro Scienze dell’Invecchiamento e Medicina Traslazionale (Ce.S.I.Me.T.) Università degli Studi “G. D’Annunzio”
Via Luigi Polacchi n. 11/13 Chieti
Directors
Patrizia Vici Teresa Gamucci Clara Natoli
CINBO
Consorzio Interuniversitario Nazionale per la Bio-Oncologia
Evento n. ECM 50-193251 per Medici Chirurghi specialisti in:
GENETICA MEDICA; ONCOLOGIA; RADIOTERAPIA; CHIRURGIA GENERALE;
CHIRURGIA PLASTICA E RICOSTRUTTIVA; GINECOLOGIA E OSTETRICIA;
ANATOMIA PATOLOGICA; MEDICINA NUCLEARE; PATOLOGIA CLINICA (LABORATORIO DI ANALISI CHIMICOCLINICHE E MICROBIOLOGIA);
RADIODIAGNOSTICA;
per Farmacisti (Farmacia Ospedaliera); per Biologi Crediti ECM: 6
si ringrazia per il contributo incondizionato:
La partecipazione è gratuita.
Le iscrizioni si accettano on line sul sito del Provider www.strategieonweb.it - pagina ECM 2017
Con il patrocino di:
Stampa Demagraf - Pescara
9.00 Registration & Welcome coffee 9.30 Wellcome from
Patrizia Vici, Teresa Gamucci, Clara Natoli
Moderators: Patrizia Vici & Teresa Gamucci
10.00 Multiple types and subtypes: breast cancer, a rare disease Domenico Angelucci
10.20 Targeting triple negative disease Andrea Michelotti
10.40 Pathways involved in hereditary breast cancer Liborio Stuppia
11.00 Deregulated Hippo pathway in breast cancer Marcello Maugeri-Saccà
11.20 Discussion leaders: from bench research into clinical care Raffaella Muraro & Saverio Alberti 11.50 Coffee break
Moderators: Lucio Laudadio & Domenico Genovesi
12.10 mTOR Pathway and mTOR Inhibitors Luca Moscetti
12.30 CDK 4/6 Inhibitors in breast cancer Patrizia Vici
12.50 Inhibiting the PI3K signaling pathway in breast cancer Antonino Grassadonia
13.10 Discussion leaders: the real word perspective Mariella Mauri & Alessandra Cassano 13.40 Light lunch
Moderators: Alberto Bafi le & Amedeo Pancotti
14.40 Endocrine therapy: the need of a personalized treatment approach Giuseppe Buono
15.00 Chemotherapy: when less is more? Marina Cazzaniga
15.20 HER2 inhibition: when more is better? Teresa Gamucci
15.40 Discussion leaders: when less is more in breast cancer treatment? Paolo Noccioli & Catia Angiolini Moderators: Corrado Ficorella & Carlo Garufi
16.10 Moving forward in breast cancer immunotherapy Clara Natoli
16.30 Anthropometrics and biomarkers of glucose metabolism in breast and ovarian cancer: from the real
world setting to the underlying pathways Maddalena Barba
16.50 Discussion leaders: barriers to translating basic knowledge into clinical practice Fiamma Buttitta & Giuseppe Naso 17.20 Take-home messages and conclusions
Liborio Stuppia Andrea Michelotti Domenico Angelucci Marcello Maugeri-Saccà
Antonino Grassadonia Patrizia Vici
Luca Moscetti
Mariella Mauri & Alessandra Cassano
Teresa Gamucci Marina Cazzaniga Giuseppe Buono
Clara Natoli
Paolo Noccioli & Catia Angiolini
Fiamma Buttitta & Giuseppe Naso Maddalena Barba
Program Faculty
Saverio Alberti [email protected] Chieti
Domenico Angelucci [email protected] Chieti
Catia Angiolini
[email protected] Firenze
Maddalena Barba
[email protected] Rome
Alberto Bafi le albertobafi [email protected] L’Aquila
Giuseppe Buono [email protected] Napoli
Fiamma Buttitta fi [email protected] Chieti
Alessandra Cassano
[email protected] Roma
Marina Cazzaniga
[email protected] Monza
Corrado Ficorella corrado.fi [email protected] L’Aquila
Teresa Gamucci [email protected] Roma
Carlo Garufi
carlo.garufi @ausl.pe.it Pescara
Domenico Genovesi [email protected] Chieti
Antonino Grassadonia [email protected] Chieti
Lucio Laudadio
[email protected] Lanciano (CH)
Marcello Maugeri-Saccà [email protected] Rome
Mariella Mauri
[email protected] Roma
Andrea Michelotti [email protected] Pisa
Luca Moscetti
[email protected] Modena
Raffaella Muraro [email protected] Chieti
Giuseppe Naso
[email protected] Roma
Clara Natoli [email protected] Chieti Paolo Noccioli [email protected] Ortona
Amedeo Pancotti [email protected] Teramo
Liborio Stuppia [email protected] Chieti
Patrizia Vici
[email protected] Rome
9.00 Registration & Welcome coffee 9.30 Wellcome from
10.00 Multiple types and subtypes: breast cancer, a rare disease 10.20 Targeting triple negative disease
10.40 Pathways involved in hereditary breast cancer 11.00 Deregulated Hippo pathway in breast cancer
12.10 mTOR Pathway and mTOR Inhibitors 12.30 CDK 4/6 Inhibitors in breast cancer
12.50 Inhibiting the PI3K signaling pathway in breast cancer 13.10
14.40 Endocrine therapy: the need of a personalized treatment approach 15.00 Chemotherapy: when less is more?
15.20 HER2 inhibition: when more is better?
15.40
16.10 Moving forward in breast cancer immunotherapy 16.30 Anthropometrics and biomarkers of glucose metabolism
16.50
17.20 Take-home messages and conclusions
Raffaella Muraro & Saverio Alberti 11.20
